Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Singapore medical journal ; : 58-quiz 66, 2014.
Artigo em Inglês | WPRIM | ID: wpr-274292

RESUMO

The Academy of Medicine (AMS) and Ministry of Health (MOH) have developed the clinical practice guidelines on Assessment and Management of Infertility at Primary Healthcare Level to provide doctors and patients in Singapore with evidence-based treatment for infertility. This article reproduces the introduction and executive summary (with recommendations from the guidelines) from the AMS-MOH clinical practice guidelines on Assessment and Management of Infertility at Primary Healthcare Level, for the information of SMJ readers. Chapters and page numbers mentioned in the reproduced extract refer to the full text of the guidelines, which are available from the Ministry of Health website: http://www.moh.gov.sg/content/moh_web/healthprofessionalsportal/doctors/guidelines/cpg_medical/2013/cpgmed_infertility.html. The recommendations should be used with reference to the full text of the guidelines. Following this article are multiple choice questions based on the full text of the guidelines.


Assuntos
Feminino , Humanos , Masculino , Medicina Baseada em Evidências , Guias como Assunto , Infertilidade , Diagnóstico , Terapêutica , Guias de Prática Clínica como Assunto , Atenção Primária à Saúde , Métodos , Padrões de Referência , Saúde Pública , Padrões de Referência , Singapura
2.
Annals of the Academy of Medicine, Singapore ; : 54-62, 2008.
Artigo em Inglês | WPRIM | ID: wpr-348330

RESUMO

<p><b>INTRODUCTION</b>Cardiovascular disease is the leading cause of death and morbidity among postmenopausal women, and oestrogen deficiency may be an important factor in its development. The role of oestrogen replacement in preventing cardiovascular disease is controversial. The aim of this descriptive review is to analyse the available data and to recommend evidence-based practice guidelines pertaining to hormone therapy in the context of cardiovascular and cerebrovascular health.</p><p><b>MATERIALS AND METHODS</b>Relevant clinical trials were identified by computerised literature search. The collated data were presented to fellow gynaecologists for review, analysis of results and discussion in a series of meetings dedicated to finding the best evidence in menopause management. The evidence was used to formulate clinical practice guidelines for the management of women with significant cardiovascular risk factors.</p><p><b>RESULTS</b>Evidence from animal studies and observational trials supported a cardio-protective effect of postmenopausal hormone therapy. More recent randomised clinical trial data have shown no significant reduction of coronary heart disease, and have confirmed a higher incidence of stroke and venous thromboembolism.</p><p><b>CONCLUSIONS</b>The evidence is widely divergent regarding postmenopausal hormone therapy and cardiovascular risk. More consistent data are available reporting an increased risk in the incidence of venous thromboembolism and stroke. It is important to be clear about the indications of hormone use and to utilise alternative modalities to promote cardiovascular health in the postmenopausal population.</p>


Assuntos
Idoso , Feminino , Humanos , Pessoa de Meia-Idade , Doenças Cardiovasculares , Transtornos Cerebrovasculares , Estrogênios , Metabolismo , Terapia de Reposição Hormonal , Menopausa , Guias de Prática Clínica como Assunto
3.
Annals of the Academy of Medicine, Singapore ; : 215-223, 2008.
Artigo em Inglês | WPRIM | ID: wpr-348297

RESUMO

<p><b>INTRODUCTION</b>The physiological changes that occur in menopause alter sexual function and affect well-being. Hormonal changes contribute significantly to reduced sexual function in older women and sexual dysfunction may well be amenable to treatment with exogenous hormones or other agents.</p><p><b>MATERIALS AND METHODS</b>Relevant clinical studies were identified by a computerised literature search. The collated data were presented to fellow gynaecologists for review, analysis of results and discussion in a series of meetings dedicated to finding the best evidence in menopause management. The evidence was assessed and used to prepare guidelines around the management of women who are affected by sexual dysfunction in menopause.</p><p><b>RESULTS</b>Hormone therapy benefits many women who have dyspareunia related to vaginal atrophy, reduced libido and decreased satisfaction, particularly if these symptoms adversely affect their quality of life. Alternative agents such as tibolone and sildenafil citrate can be useful adjuncts.</p><p><b>CONCLUSIONS</b>It is increasingly important to recognise postmenopausal sexual dysfunction. Treatment of this syndrome must be individualised to the specific complaints of each woman. Hormones and other agents are relevant treatment options for properly-selected women.</p>


Assuntos
Feminino , Humanos , Menopausa , Disfunções Sexuais Fisiológicas , Terapêutica , Disfunções Sexuais Psicogênicas , Terapêutica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA